NEW YORK – Sema4 on Tuesday announced that it had entered into a research collaboration with Janssen to identify patients for enrollment onto Janssen's oncology clinical trials.
NEW YORK – Sema4 on Tuesday announced that it had entered into a research collaboration with Janssen to identify patients for enrollment onto Janssen's oncology clinical trials.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.